CD274 and neoplasm: There are three major predictive biomarkers associated with ICI namely PD-L1 expression, microsatellite stability (MSI), and tumor mutation burden (TMB).2,3 While PD-L1 is a protein expression biomarker, MSI and TMB are genome-wide signatures derived from tumor DNA profiling.